Table 2

Primary efficacy variables (n = 30)

PEFSymptoms
AMPMDayNight
FP (adj mean)3113160.30.3
BDP (adj mean)3083120.40.3
Diff (adj mean)2.64.2−0.1−0.05
(95% CI)(−1.8 to 7.0)(−1.2 to 9.5)(−0.8 to 0.02)(−0.14 to 0.03)
  • There were no significant differences between treatments for peak expiratory flow (PEF) rates or symptom scores.